Arkolith/Insider Trading/AQST/Form 4

Boyd Peter E.

See RemarksAquestive Therapeutics, Inc. (AQST) · full profile →Form 4 · filed Sep 29, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$63K
Net Open-Market Flow
-$63K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 26, 2025Sell(S)10K$6.30$63K278K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001214659-25-014287) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML